Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
Trials
View this publicationTrials
View this publicationPublication categories: Top publication
Briefings in bioinformatics
View this publicationBriefings in bioinformatics
View this publicationJournal of leukocyte biology
View this publicationHuman mutation
View this publicationLiver cancer
View this publicationGait & posture
View this publicationEuropean heart journal
View this publicationScience (New York, N.Y.)
View this publicationFrontiers in medicine
View this publication